REL and neoplasm: In contrast, mice with conditional ablation of Ikzf2, Pten, Rcor 1, or Rel, for instance, display no (or limited) signs of autoimmunity while enabling enhanced tumor clearance, perhaps indicating “safer” therapeutic targets in terms of adverse effects.